CD36 and cancer: In several types of cancer, there is a positive correlation between tumor CD36 expression and poor clinical outcome (Abd El-Aziz et al., 2013; Hale et al., 2014; Deng et al., 2019; Luanpitpong et al., 2019; Haidari et al., 2021; Jeong et al., 2021; Luo et al., 2021; Yang et al., 2021; Pardo et al., 2022).